Richard Straube

Richard Straube

No más puestos en curso

Fortuna: 31 $ al 31/05/2026

74 años
Health Technology
Consumer Services
Finance

Perfil

Richard C.
Straube
worked as Senior Director-Clinical Research & Immunology at Centocor, Inc. from 1988 to 1993.
From 1993 to 1995, served as Director-Medical Affairs at T Cell Sciences, Inc. Between 1995 and 1997, held the position of Director-Clinical Investigations at Ohmeda, Inc. From 1998 to 2007, was Chief Scientific Officer and Executive VP-R&D at INO Therapeutics LLC.
Held the role of Chief Medical Officer at Critical Biologics Corp.
from 2007 to 2009.
From 2009 to 2014, was Chief Medical Officer at Stealth BioTherapeutics, Inc. Served as Chief Medical Officer & Senior Vice President at Soligenix, Inc. from 2014 to 2025.
Also held positions as Faculty Member at the University of California San Diego and Principal at Inomax LLC (Florida).
Education includes a doctorate from The University of Chicago in 1977 and a graduate degree from the London School of Hygiene & Tropical Medicine in 1982.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
11/12/2025 34 ( 0 % ) 31 $ 31/05/2026

Antiguos cargos conocidos de Richard Straube.

EmpresasCargoFin
SOLIGENIX, INC. Director Técnico/Científico/I+D 12/08/2025
Director Técnico/Científico/I+D 01/01/2014
Director Técnico/Científico/I+D 01/01/2009
Director Técnico/Científico/I+D 01/01/2007
Ohmeda, Inc.
Corporate Officer/Principal 02/01/1997
Ver el detalle de la experiencia de Richard Straube.

Formación de Richard Straube.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

91

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Finance

Ohmeda, Inc.

Health Technology

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN